Showing results (421-430 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 9, 2024
CNS B cell infiltration in tumefactive anti-myelin oligodendrocyte glycoprotein antibody-associated diseaseRyotaro Ikeguchi, Natsuki Kanda, Masaki Kobayashi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2024
Impact of race and socioeconomic deprivation on clinical outcomes and healthcare utilization in pediatric multiple sclerosisKelsey E Poisson, Stacey S Cofield, Jayne M Ness
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 26, 2024
Quality of life is impaired in myelin oligodendrocyte glycoprotein antibody associated diseaseYana Said, Dimitrios C Ladakis, Julia M Lefelar, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 14, 2024
Pregnancy characteristics in Egyptian female patients with NMOSDAdel Hassanein Gad, Nirmeen Kishk, Nevin M Shalaby, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 2, 2023
Diet-induced changes in functional disability are mediated by fatigue in relapsing-remitting multiple sclerosis: A secondary analysis of the WAVES randomized parallel-arm trialLandon J Crippes, Solange M Saxby, Farnoosh Shemirani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 19, 2023
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registryEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 7, 2023
Cutaneous presentation of cryptococcal infection with subclinical central nervous system involvement secondary to fingolimod therapyShin Yee Chey, Niamh-Anna O'Sullivan, Trevor Beer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 15, 2024
Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programmeT A Hardy, P Aouad, M H Barnett, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 8, 2024
Subclinical atherosclerosis in multiple sclerosisRuth Ann Marrie, Ronak Patel, Stephen Allan Schaffer
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 29, 2024
Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorderMichael T G Hayes, Robert J Adam, Pamela A McCombe, et al.
Pageof 62